Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析

◆英語タイトル:Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0151
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Becton Dickinson and Co (BDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.

Becton Dickinson and Co Key Recent Developments

Nov 05,2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
Oct 23,2019: AdvaMed Statement on BD Sterilization Plant in Georgia
Sep 26,2019: BD announces leadership succession plan
Sep 19,2019: Community Clinics receive grant for Point-of-Care Diagnostics
Aug 29,2019: BD awards $1.2 million in grants to community health centers that help vulnerable patients more effectively manage medications

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Becton Dickinson and Co – Key Facts
Becton Dickinson and Co – Key Employees
Becton Dickinson and Co – Key Employee Biographies
Becton Dickinson and Co – Major Products and Services
Becton Dickinson and Co – History
Becton Dickinson and Co – Company Statement
Becton Dickinson and Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Business Unit
Section 2 – Company Analysis
Company Overview
Becton Dickinson and Co – Business Description
Business Segment: BD Interventional
Overview
Performance
Business Segment: BD Life Sciences
Overview
Performance
Business Segment: BD Medical
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Greater Asia
Target Markets
Performance
Geographical Segment: Others
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Becton Dickinson and Co – Corporate Strategy
Becton Dickinson and Co – SWOT Analysis
SWOT Analysis – Overview
Becton Dickinson and Co – Strengths
Becton Dickinson and Co – Weaknesses
Becton Dickinson and Co – Opportunities
Becton Dickinson and Co – Threats
Becton Dickinson and Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2013 to YTD 2019
Becton Dickinson and Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia
Sep 26, 2019: BD announces leadership succession plan
Sep 19, 2019: Community Clinics receive grant for Point-of-Care Diagnostics
Aug 29, 2019: BD awards $1.2 million in grants to community health centers that help vulnerable patients more effectively manage medications
Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance
Jul 25, 2019: BD Statement on Georgia facilities
Jun 27, 2019: United States and Indonesia expand collaboration to end tuberculosis
Jun 21, 2019: BD Statement on Voluntary Recall of BD Vacutainer Fluoride Tubes for Blood Alcohol Determinations
Jun 19, 2019: BD Debuts New Software for Flow Cytometry Analysis
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Becton Dickinson and Co, Key Facts
Becton Dickinson and Co, Key Employees
Becton Dickinson and Co, Key Employee Biographies
Becton Dickinson and Co, Major Products and Services
Becton Dickinson and Co, History
Becton Dickinson and Co, Other Locations
Becton Dickinson and Co, Subsidiaries
Becton Dickinson and Co, Business Unit
Becton Dickinson and Co, Key Competitors
Becton Dickinson and Co, Ratios based on current share price
Becton Dickinson and Co, Annual Ratios
Becton Dickinson and Co, Annual Ratios (Cont...1)
Becton Dickinson and Co, Annual Ratios (Cont...2)
Becton Dickinson and Co, Interim Ratios
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2013 to YTD 2019
Becton Dickinson and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Becton Dickinson and Co, Performance Chart (2015 - 2019)
Becton Dickinson and Co, Ratio Charts
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Becton Dickinson and Co (BDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Delek Group Ltd:企業のM&A・事業提携・投資動向
    Delek Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Navitas Ltd:企業の戦略的SWOT分析
    Navitas Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Estee Lauder Companies Inc:戦略・SWOT・企業財務分析
    Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務分析
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AviAlliance GmbH:企業の戦略・SWOT・財務情報
    AviAlliance GmbH - Strategy, SWOT and Corporate Finance Report Summary AviAlliance GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Carraro Spa:戦略・SWOT・企業財務分析
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kosmos Energy Ltd (KOS):企業の財務・戦略的SWOT分析
    Kosmos Energy Ltd (KOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hollysys Automation Technologies Ltd:企業の戦略・SWOT・財務分析
    Hollysys Automation Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Hollysys Automation Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Infratil Ltd (IFT)-エネルギー分野:企業M&A・提携分析
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • Data Respons ASA (DAT):企業の財務・戦略的SWOT分析
    Summary Data Respons ASA (Data Respons) is an information technology company that offers software products and embedded solutions. The company's products include storage and memory, handheld tablets, embedded boards, panel PCs and displays, systems and platforms, and industrial communication product …
  • Curemark LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates. Its drug candidate CM-AT is a clinical trial for autism, ADHD, …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析
    Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Mauna Kea Technologies SAS (MKEA)-医療機器分野:企業M&A・提携分析
    Summary Mauna Kea Technologies SAS (MKT) is a medical device company that develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. The company’s product includes cellvizio. Its cellvizio is an endomicroscopy platform that provides micr …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Vattenfall:企業の戦略・SWOT・財務情報
    Vattenfall - Strategy, SWOT and Corporate Finance Report Summary Vattenfall - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM):企業の財務・戦略的SWOT分析
    Summary J B Chemicals and Pharmaceuticals Ltd (JBCPL) is a pharmaceutical company that manufactures and markets pharmaceutical formulations. The company provides products such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, capsules, and others. It provides contract …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆